Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making ...

SKN, will advance to an extension clinical study in patients with cutaneous lupus erythematosus, a painful, disfiguring skin ...

Perth-based medical technology company Proteomics International has begun selling two of its diagnostic blood tests directly ...

Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug. Three months later, all of them were still doing better ...

We live in a wealthy country where this situation has been allowed to persist. Responsibility is not shared equally. Those ...

Neurizon Therapeutics, the Melbourne-based biotechnology company developing a treatment for the fatal neurological disease ...

Vitura Health has updated investors, confirming that Bupa will discontinue its international patient referrals from the Doctors on Demand telehealth business.

Where the US has, albeit messily, built parallel pathways into Medicare and Medicaid, Australia's single-payer system has so far failed to produce even a recommendation beyond a relatively small ...

Telix Pharmaceuticals has completed enrolment in its pivotal BiPASS trial, moving the Australian company closer to testing ...

Arovella Therapeutics has taken a step toward treating blood cancer patients with donor-derived cells rather than their own, ...

Nic Horridge, general manager of Roche Pharmaceuticals Australia, said the relocation offered an opportunity to rethink the ...

Priceline Pharmacy general manager of marketing Corrina Brazel said almost 300,000 Australian women begin their journey into ...